Cover Image

DETECTING PAINLESS MYOCARDIAL ISCHEMIA IN A PATIENT WITH RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION

Restenosis is a complication of percutaneous coronary interventions which results in the destabilization of coronary heart disease. Presents a clinical case of detection of restenosis using stress Echocardiography one year after percutaneous coronary intervention.

Saved in:

Bibliographic Details
Main Authors:	M. A. Elkanova (Author), V. N. Shitov (Author), U. V. Botvina (Author), V. V. Lopukhova (Author), M. A. Saidova (Author), Y. A. Karpov (Author)
Format:	Book
Published:	«REMEDIUM GROUP» Ltd., 2016-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention
by: Dedi Wihanda, et al.
Published: (2015)

Serum Homocysteine Level Predictive Capability for Severity of Restenosis Post Percutaneous Coronary Intervention
by: Jiqiang Guo, et al.
Published: (2022)

Relationship between the extent of coronary artery disease and in-stent restenosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Erkan Yıldırım, et al.
Published: (2017)

Albumin to globulin ratio was associated with in‐stent restenosis and revascularization events after percutaneous coronary intervention
by: Rui Zhang, et al.
Published: (2022)

CLINICAL VARIABLES RELATED TO PERCUTANEOUS CORONARY INTERVENTION RESULTS IN MYOCARDIAL ISCHEMIA PATIENTS
by: Yanier Coll Muñoz, et al.
Published: (2011)

CLINICAL VARIABLES RELATED TO PERCUTANEOUS CORONARY INTERVENTION RESULTS IN MYOCARDIAL ISCHEMIA PATIENTS
by: Yanier Coll Muñoz, et al.
Published: (2011)

CASE OF LEFT ATRIUM INTRAMURAL HEMATOMA AFTER PERCUTANEOUS CORONARY INTERVENTION
by: T. S. Sukhinina, et al.
Published: (2020)

Changes of miR-130a and ET-1 and Their Predictive Value for In-Stent Restenosis after Percutaneous Coronary Intervention
by: Hongliang LIU, et al.
Published: (2020)

REPERFUSION MYOCARDIAL INJURY AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENT WITH ACUTE ST-ELEVATION MYOCARDIAL INFARCTION. CLINICAL OBSERVATION
by: N. A. Kosheleva, et al.
Published: (2016)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016)

Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2020)

Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome
by: M. Yu. Gilyarov, et al.
Published: (2021)

Silent Myocardial Ischemia in Patients after Permanent Coronary Intervention
by: A. I. Abdrahmanova, et al.
Published: (2022)

Analysis of influencing factors for restenosis after percutaneous transluminal angioplasty in hemodialysis patients
by: Shen Zhan, et al.
Published: (2024)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019)

Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: A. V. Panov
Published: (2021)

Frequency and Prognostic Value of Acute Periprocedural Myocardial Injury in Elective Percutaneous Coronary Interventions
by: E. O. Nalesnik, et al.
Published: (2024)

IMPACT OF LOCUS 9P21.3 SINGLE NUCLEOTIDE POLYMORPHISMS ON CORONARY ATHEROSCLEROSIS SEVERITY AND LONG-TERM OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENT WITH MYOCARDIAL INFARCTION
by: P. A. Shesternya, et al.
Published: (2015)

IMPACT OF LOCUS 9P21.3 SINGLE NUCLEOTIDE POLYMORPHISMS ON CORONARY ATHEROSCLEROSIS SEVERITY AND LONG-TERM OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENT WITH MYOCARDIAL INFARCTION
by: P. A. Shesternya, et al.
Published: (2015)

Gene Therapy for the Prevention of in- Stent Restenosis Post Coronary Angioplasty
by: P Ranjzad, et al.
Published: (2005)

Gene Therapy for the Prevention of in- Stent Restenosis Post Coronary Angioplasty
by: P Ranjzad, et al.
Published: (2005)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015)

The use of percutaneous coronary intervention in black and white veterans with acute myocardial infarction
by: Sales Anne E, et al.
Published: (2006)

Comparative efficacy of different Chinese patent medicines in preventing restenosis after percutaneous coronary intervention: a systematic review and Bayesian network meta-analysis of randomized clinical trials
by: Jiasai Fan, et al.
Published: (2024)

HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE?
by: I. S. Yavelov, et al.
Published: (2017)

Effect of percutaneous coronary intervention in diabetic patients with non-ST elevated myocardial infarction
by: MSI Tipu Chowdhury, et al.
Published: (2021)

DETERMINANTS OF MYOCARDIAL INFARCTION OUTCOMES IN A NON-PERCUTANEOUS CORONARY INTERVENTION HOSPITAL IN JAKARTA
by: Talitha Syifa Laili, et al.
Published: (2023)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
by: Son V Pham, et al.
Published: (2010)

Painless cheek nodule
by: Yanci A. Algarin, BS, et al.
Published: (2024)

Stress and Vascular Responses: Anti-inflammatory Therapeutic Strategy Against Atherosclerosis and Restenosis After Coronary Intervention
by: Shiro Kitamoto, et al.
Published: (2003)

Acute lower limb ischemia following Angio-Seal deployment after transfemoral percutaneous coronary intervention
by: Michał Walczewski, et al.
Published: (2019)

Machine learning for prediction of bleeding in acute myocardial infarction patients after percutaneous coronary intervention
by: Xueyan Zhao, et al.
Published: (2023)

Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
by: Mohamed Khalfallah, et al.
Published: (2022)

Expediency of сitoprotective treatment of patients with acute myocardial infarction, who were performed percutaneous coronary intervention
by: M. Shved, et al.
Published: (2020)

Clinical and laboratory predictors of early mortality in patients with acute myocardial infarction treated with primary percutaneous coronary intervention
by: Ružičić Dušan P., et al.
Published: (2016)

FUNCTIONAL ACTIVITY OF ENDOTHELIUM IN THE SYSTEMIC AND LOCAL BLOOD FLOW IN PATIENTS WITH OBLITERATING ATHEROSCLEROSIS AND RESTENOSIS AFTER FEMOROPOPLITEAL BYPASS SURGERY
by: V.A. LAZARENKO, et al.
Published: (2023)

Contrast-associated acute kidney injury after percutaneous coronary interventions in patients with acute coronary syndrome: a real-world study
by: Vladimir A. Kuznetsov, et al.
Published: (2022)

Haemodynamic Patterns of Severe Aortic Stenosis
by: A. E. Komlev, et al.
Published: (2020)

Institutional Variance in Mortality after Percutaneous Coronary Intervention for Acute Myocardial Infarction in Korea, Japan, and Taiwan
by: Hayato Yamana, et al.
Published: (2023)